FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W862092125> ?p ?o ?g. }

• W862092125 endingPage "699" @default.
• W862092125 startingPage "692" @default.
• W862092125 abstract "There is growing recognition that glial proinflammatory activation importantly contributes to the rewarding and reinforcing effects of a variety of drugs of abuse, including cocaine, methamphetamine, opioids, and alcohol. It has recently been proposed that glia are recognizing, and becoming activated by, such drugs as a CNS immunological response to these agents being xenobiotics; that is, substances foreign to the brain. Activation of glia, primarily microglia, by various drugs of abuse occurs via toll like receptor 4 (TLR4). The detection of such xenobiotics by TLR4 results in the release of glial neuroexcitatory and neurotoxic substances. These glial products of TLR4 activation enhance neuronal excitability within brain reward circuitry, thereby enhancing their rewarding and reinforcing effects. Indeed, selective pharmacological blockade of TLR4 activation, such as with the non-opioid TLR4 antagonist (+)-naltrexone, suppresses a number of indices of drug reward/reinforcement. These include: conditioned place preference, self-administration, drugprimed reinstatement, incubation of craving, and elevations of nucleus accumbens shell dopamine. Notably, TLR4 blockade fails to alter self-administration of food, indicative of a selective effect on drugs of abuse. Genetic disruption of TLR4 signaling recapitulates the effects of pharmacological TLR4 blockade, providing converging lines of evidence of a central importance of TLR4. Taken together, multiple lines of evidence converge to raise TLR4 as a promising therapeutic target for drug abuse." @default.
• W862092125 created "2016-06-24" @default.
• W862092125 creator A5011957342 @default.
• W862092125 creator A5023010090 @default.
• W862092125 creator A5025282582 @default.
• W862092125 creator A5037100405 @default.
• W862092125 creator A5072565784 @default.
• W862092125 creator A5076696226 @default.
• W862092125 date "2015-06-24" @default.
• W862092125 modified "2023-10-14" @default.
• W862092125 title "Targeting the Toll of Drug Abuse: The Translational Potential of Toll-Like Receptor 4" @default.
• W862092125 cites W1510797412 @default.
• W862092125 cites W1560220156 @default.
• W862092125 cites W1562313142 @default.
• W862092125 cites W1596867242 @default.
• W862092125 cites W1606879955 @default.
• W862092125 cites W1820118415 @default.
• W862092125 cites W1837192457 @default.
• W862092125 cites W187041481 @default.
• W862092125 cites W1891696008 @default.
• W862092125 cites W1922433683 @default.
• W862092125 cites W1965279522 @default.
• W862092125 cites W1970417151 @default.
• W862092125 cites W1971023897 @default.
• W862092125 cites W1971776336 @default.
• W862092125 cites W1972467982 @default.
• W862092125 cites W1973404097 @default.
• W862092125 cites W1974271654 @default.
• W862092125 cites W1975569088 @default.
• W862092125 cites W1975744086 @default.
• W862092125 cites W1975931952 @default.
• W862092125 cites W1978521888 @default.
• W862092125 cites W1983623172 @default.
• W862092125 cites W1988795126 @default.
• W862092125 cites W1990368996 @default.
• W862092125 cites W1994190235 @default.
• W862092125 cites W1998904480 @default.
• W862092125 cites W2000253977 @default.
• W862092125 cites W2012162544 @default.
• W862092125 cites W201344284 @default.
• W862092125 cites W2015266566 @default.
• W862092125 cites W2015455559 @default.
• W862092125 cites W2017453007 @default.
• W862092125 cites W2025400268 @default.
• W862092125 cites W2026807092 @default.
• W862092125 cites W2030689820 @default.
• W862092125 cites W2034088074 @default.
• W862092125 cites W2035605437 @default.
• W862092125 cites W2037566902 @default.
• W862092125 cites W2038672096 @default.
• W862092125 cites W2040850452 @default.
• W862092125 cites W2042794266 @default.
• W862092125 cites W2047610987 @default.
• W862092125 cites W2048808462 @default.
• W862092125 cites W2053483725 @default.
• W862092125 cites W2055068047 @default.
• W862092125 cites W2059334369 @default.
• W862092125 cites W2066067415 @default.
• W862092125 cites W2066848874 @default.
• W862092125 cites W2071488336 @default.
• W862092125 cites W2073211159 @default.
• W862092125 cites W2076276989 @default.
• W862092125 cites W2081128169 @default.
• W862092125 cites W2085069683 @default.
• W862092125 cites W2090785150 @default.
• W862092125 cites W2091155982 @default.
• W862092125 cites W2108163830 @default.
• W862092125 cites W2110060230 @default.
• W862092125 cites W2113754496 @default.
• W862092125 cites W2124355299 @default.
• W862092125 cites W2125351457 @default.
• W862092125 cites W2127934565 @default.
• W862092125 cites W2128533924 @default.
• W862092125 cites W2129319296 @default.
• W862092125 cites W2141054513 @default.
• W862092125 cites W2143490729 @default.
• W862092125 cites W2144003555 @default.
• W862092125 cites W2159578148 @default.
• W862092125 cites W2171260427 @default.
• W862092125 cites W2243566379 @default.
• W862092125 cites W2296152323 @default.
• W862092125 cites W2324814975 @default.
• W862092125 cites W2417827509 @default.
• W862092125 doi "https://doi.org/10.2174/1871527314666150529132503" @default.
• W862092125 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5548122" @default.
• W862092125 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26022268" @default.
• W862092125 hasPublicationYear "2015" @default.
• W862092125 type Work @default.
• W862092125 sameAs 862092125 @default.
• W862092125 citedByCount "65" @default.
• W862092125 countsByYear W8620921252015 @default.
• W862092125 countsByYear W8620921252016 @default.
• W862092125 countsByYear W8620921252017 @default.
• W862092125 countsByYear W8620921252018 @default.
• W862092125 countsByYear W8620921252019 @default.
• W862092125 countsByYear W8620921252020 @default.
• W862092125 countsByYear W8620921252021 @default.
• W862092125 countsByYear W8620921252022 @default.

• next